These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 7658972

  • 1. [Treatment of anemia in children undergoing chronic hemodialysis with recombinant human erythropoietin].
    Rendo P, Biscigniano L, Turconi A, Sánchez Avalos JC, Greco J.
    Medicina (B Aires); 1994; 54(5 Pt 1):392-8. PubMed ID: 7658972
    [Abstract] [Full Text] [Related]

  • 2. Anemia of chronic renal failure: treatment with erythropoietin.
    Navarro M, Alonso A, Avilla JM, Espinosa L.
    Child Nephrol Urol; 1991; 11(3):146-51. PubMed ID: 1777893
    [Abstract] [Full Text] [Related]

  • 3. [Recombinant human erythropoietin: 18 months of continuous use in substitution hemodialysis].
    Canaud B, Polito-Bouloux C, Rivory JP, Donnadieu P, Taib J, Florence P, Mion C.
    Nephrologie; 1990; 11(1):5-10. PubMed ID: 2374643
    [Abstract] [Full Text] [Related]

  • 4. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS, Blum M, Agbaria Z, Deutsch V, Irony M, Schwartz D, Baruch R, Yachnin T, Steinbruch S, Iaina A.
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [Abstract] [Full Text] [Related]

  • 5. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration].
    Zehnder C, Blumberg A.
    Schweiz Med Wochenschr; 1990 Feb 17; 120(7):217-20. PubMed ID: 2309110
    [Abstract] [Full Text] [Related]

  • 6. [Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study].
    Sinnassamy P, Andre JL, Treize G, Leroy B.
    Arch Fr Pediatr; 1993 Mar 17; 50(3):201-8. PubMed ID: 8338412
    [Abstract] [Full Text] [Related]

  • 7. A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis.
    Berns JS, Rudnick MR, Cohen RM.
    Clin Nephrol; 1992 May 17; 37(5):264-7. PubMed ID: 1606777
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Epoetin omega for treatment of anemia in maintenance hemodialysis patients.
    Sikole A, Spasovski G, Zafirov D, Polenakovic M.
    Clin Nephrol; 2002 Mar 17; 57(3):237-45. PubMed ID: 11924756
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H, Mimura T, Honda N.
    Hemodial Int; 2008 Oct 17; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [Abstract] [Full Text] [Related]

  • 16. Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.
    Ramírez B, Flores A, Pérez F, Córdoba C, García L, Vázquez G.
    Transplant Proc; 1991 Apr 17; 23(2):1833-4. PubMed ID: 2053170
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.